| Literature DB >> 28390214 |
Juan Du1, Yu Shrike Zhang2, Divia Hobson3, Per Hydbring4.
Abstract
Nanoparticles (NPs) are found in numerous applications used to modulate the immune system. They serve as drug delivery carriers or vaccine adjuvants and are utilized as therapeutics against a variety of diseases. NPs can be engineered to target distinct cellular components representing multiple pathways of immunity. The combination of NPs with immune system-targeting moieties has paved the way for improved targeted immune therapies. Here we provide an update of recent progress in this field.Mesh:
Year: 2017 PMID: 28390214 DOI: 10.1016/j.drudis.2017.03.013
Source DB: PubMed Journal: Drug Discov Today ISSN: 1359-6446 Impact factor: 7.851